Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| tat Gene Products, Human Immunodeficiency Virus | 4 | 2019 | 130 | 1.530 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2022 | 568 | 1.020 |
Why?
|
| RNA Phages | 1 | 2021 | 4 | 0.900 |
Why?
|
| Vaccines, Virus-Like Particle | 1 | 2021 | 34 | 0.870 |
Why?
|
| HIV-1 | 9 | 2021 | 6757 | 0.840 |
Why?
|
| Protein Engineering | 2 | 2021 | 551 | 0.690 |
Why?
|
| Influenza Vaccines | 5 | 2022 | 672 | 0.640 |
Why?
|
| Receptors, CCR5 | 1 | 2019 | 442 | 0.630 |
Why?
|
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2015 | 53 | 0.580 |
Why?
|
| Open Reading Frames | 1 | 2019 | 840 | 0.570 |
Why?
|
| HIV Seropositivity | 1 | 2019 | 893 | 0.510 |
Why?
|
| Cytidine Deaminase | 1 | 2015 | 234 | 0.500 |
Why?
|
| B-Lymphocytes | 3 | 2021 | 4861 | 0.490 |
Why?
|
| Influenza, Human | 5 | 2022 | 1344 | 0.480 |
Why?
|
| Recombination, Genetic | 2 | 2015 | 1708 | 0.460 |
Why?
|
| Influenza A virus | 3 | 2022 | 452 | 0.450 |
Why?
|
| HIV Infections | 6 | 2021 | 15538 | 0.400 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 4293 | 0.400 |
Why?
|
| RNA Interference | 1 | 2019 | 3026 | 0.390 |
Why?
|
| Curcumin | 3 | 2015 | 98 | 0.380 |
Why?
|
| India | 6 | 2021 | 1967 | 0.310 |
Why?
|
| Genes, nef | 1 | 2021 | 56 | 0.210 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 1 | 2021 | 153 | 0.200 |
Why?
|
| Antigens, Viral | 2 | 2022 | 1153 | 0.200 |
Why?
|
| Epitopes | 3 | 2022 | 2646 | 0.190 |
Why?
|
| Coronavirus | 1 | 2021 | 146 | 0.190 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2020 | 418 | 0.180 |
Why?
|
| Antibody Specificity | 1 | 2021 | 1170 | 0.180 |
Why?
|
| Lentivirus | 1 | 2022 | 544 | 0.180 |
Why?
|
| Epitope Mapping | 1 | 2019 | 300 | 0.180 |
Why?
|
| Phylogeny | 3 | 2015 | 2799 | 0.180 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 874 | 0.180 |
Why?
|
| Gene Library | 1 | 2021 | 1094 | 0.170 |
Why?
|
| Geography | 1 | 2021 | 681 | 0.170 |
Why?
|
| Virus Internalization | 1 | 2022 | 463 | 0.170 |
Why?
|
| Influenza in Birds | 1 | 2018 | 65 | 0.170 |
Why?
|
| Host-Parasite Interactions | 1 | 2019 | 291 | 0.160 |
Why?
|
| Zoonoses | 1 | 2018 | 146 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 139 | 0.150 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 3 | 2022 | 152 | 0.150 |
Why?
|
| Valerian | 1 | 2015 | 4 | 0.150 |
Why?
|
| Genes, Viral | 1 | 2018 | 774 | 0.150 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2021 | 472 | 0.150 |
Why?
|
| Mice, Transgenic | 4 | 2021 | 9927 | 0.150 |
Why?
|
| Cell Death | 2 | 2019 | 1738 | 0.150 |
Why?
|
| Antibodies, Viral | 3 | 2022 | 2930 | 0.140 |
Why?
|
| Species Specificity | 1 | 2019 | 2619 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2017 | 384 | 0.130 |
Why?
|
| Tumor Escape | 1 | 2017 | 328 | 0.130 |
Why?
|
| Gene Products, vpr | 1 | 2013 | 38 | 0.130 |
Why?
|
| Calcineurin | 1 | 2015 | 227 | 0.130 |
Why?
|
| Phylogeography | 1 | 2014 | 85 | 0.130 |
Why?
|
| Ligands | 1 | 2021 | 3297 | 0.130 |
Why?
|
| Molecular Typing | 1 | 2014 | 117 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2015 | 14215 | 0.120 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 254 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2015 | 2926 | 0.120 |
Why?
|
| Human Immunodeficiency Virus Proteins | 1 | 2013 | 67 | 0.120 |
Why?
|
| AIDS Vaccines | 1 | 2020 | 914 | 0.120 |
Why?
|
| Immunotherapy | 3 | 2022 | 4057 | 0.120 |
Why?
|
| NFATC Transcription Factors | 1 | 2015 | 397 | 0.120 |
Why?
|
| Parkinsonian Disorders | 1 | 2015 | 260 | 0.120 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2013 | 156 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2021 | 3093 | 0.120 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 18748 | 0.110 |
Why?
|
| Genes, vpr | 1 | 2011 | 22 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 2264 | 0.110 |
Why?
|
| HIV Long Terminal Repeat | 1 | 2011 | 83 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2015 | 456 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2019 | 3701 | 0.110 |
Why?
|
| Glioma | 2 | 2017 | 3292 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2021 | 6666 | 0.100 |
Why?
|
| Exons | 2 | 2014 | 2472 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2020 | 3179 | 0.100 |
Why?
|
| Vaccination | 1 | 2021 | 2864 | 0.090 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2726 | 0.090 |
Why?
|
| Phosphorylation | 3 | 2017 | 8720 | 0.090 |
Why?
|
| Corpus Striatum | 1 | 2015 | 1252 | 0.090 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 1 | 2011 | 358 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2159 | 0.090 |
Why?
|
| Apoptosis | 3 | 2014 | 10085 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2015 | 1003 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2017 | 10362 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2593 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4926 | 0.080 |
Why?
|
| Genotype | 2 | 2021 | 12863 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 1796 | 0.080 |
Why?
|
| Humans | 24 | 2022 | 708843 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1849 | 0.080 |
Why?
|
| Pandemics | 2 | 2018 | 7089 | 0.070 |
Why?
|
| Animals | 11 | 2022 | 170486 | 0.070 |
Why?
|
| Immunity, Humoral | 2 | 2020 | 579 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 2035 | 0.070 |
Why?
|
| Antigens | 2 | 2022 | 1507 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 4317 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 2715 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2019 | 41081 | 0.060 |
Why?
|
| Young Adult | 4 | 2021 | 55940 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2019 | 4310 | 0.060 |
Why?
|
| Signal Transduction | 5 | 2020 | 23950 | 0.060 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2022 | 88 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 13714 | 0.060 |
Why?
|
| Adolescent | 4 | 2021 | 84718 | 0.050 |
Why?
|
| Mice | 7 | 2022 | 80876 | 0.050 |
Why?
|
| Child | 3 | 2021 | 73636 | 0.050 |
Why?
|
| Male | 8 | 2021 | 349524 | 0.050 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2020 | 27 | 0.050 |
Why?
|
| Genes, MHC Class I | 1 | 2021 | 280 | 0.050 |
Why?
|
| Female | 8 | 2021 | 375205 | 0.050 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2020 | 179 | 0.050 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2020 | 219 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7965 | 0.050 |
Why?
|
| Complementarity Determining Regions | 1 | 2019 | 160 | 0.050 |
Why?
|
| HIV Antigens | 1 | 2020 | 348 | 0.050 |
Why?
|
| Interferon Regulatory Factors | 1 | 2020 | 280 | 0.050 |
Why?
|
| Antibody Affinity | 1 | 2019 | 260 | 0.040 |
Why?
|
| Mutation | 4 | 2021 | 29262 | 0.040 |
Why?
|
| Brain Neoplasms | 2 | 2017 | 8776 | 0.040 |
Why?
|
| Host Specificity | 1 | 2018 | 54 | 0.040 |
Why?
|
| Ethylnitrosourea | 1 | 2017 | 56 | 0.040 |
Why?
|
| Birds | 1 | 2018 | 154 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2017 | 2563 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2019 | 341 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 570 | 0.040 |
Why?
|
| Plasma Cells | 1 | 2020 | 591 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2017 | 3021 | 0.040 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2019 | 648 | 0.040 |
Why?
|
| Adult | 5 | 2021 | 211041 | 0.040 |
Why?
|
| Mass Vaccination | 1 | 2018 | 106 | 0.040 |
Why?
|
| Rhizome | 1 | 2015 | 6 | 0.040 |
Why?
|
| Feces | 1 | 2022 | 1365 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2017 | 452 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 1527 | 0.040 |
Why?
|
| Middle Aged | 4 | 2021 | 213752 | 0.040 |
Why?
|
| Olfactory Perception | 1 | 2015 | 54 | 0.040 |
Why?
|
| Diarylheptanoids | 1 | 2014 | 4 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2022 | 834 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2013 | 5456 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2015 | 375 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 311 | 0.030 |
Why?
|
| Antibodies | 1 | 2022 | 2431 | 0.030 |
Why?
|
| Mesencephalon | 1 | 2015 | 322 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 927 | 0.030 |
Why?
|
| Smell | 1 | 2015 | 239 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 298 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2015 | 6127 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2022 | 2847 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2020 | 991 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2498 | 0.030 |
Why?
|
| HIV Antibodies | 1 | 2019 | 1258 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 1484 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1728 | 0.030 |
Why?
|
| Encephalitis | 1 | 2015 | 446 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1730 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2017 | 1158 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 19800 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2013 | 1914 | 0.030 |
Why?
|
| Alleles | 1 | 2022 | 7090 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2673 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 513 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 5908 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2015 | 1812 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2015 | 1292 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 22989 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 3812 | 0.020 |
Why?
|
| Rats | 2 | 2017 | 25094 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2877 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 16959 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 2013 | 681 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 1971 | 0.020 |
Why?
|
| Virus Replication | 1 | 2017 | 2524 | 0.020 |
Why?
|
| Spleen | 1 | 2015 | 2473 | 0.020 |
Why?
|
| Dopamine | 1 | 2015 | 1584 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 2281 | 0.020 |
Why?
|
| Astrocytes | 1 | 2015 | 1229 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2013 | 1712 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 2138 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 3645 | 0.020 |
Why?
|
| Antioxidants | 1 | 2015 | 1678 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2019 | 2048 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 3258 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 4489 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 3693 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3708 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4941 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 6156 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 2971 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2018 | 2768 | 0.020 |
Why?
|
| Motor Activity | 1 | 2015 | 2749 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 5112 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2019 | 20170 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2020 | 11718 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2015 | 6048 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 6068 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10019 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 11239 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10803 | 0.010 |
Why?
|
| Neurons | 1 | 2015 | 9385 | 0.010 |
Why?
|
Concepts
(198)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(25)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_